Clinical Trial Update: everlinQ Endovascular Access Systems Enhancements (EASE-2) Study [NA]

View source ↗

Summary

This clinical trial update reports on the EASE-2 study evaluating enhancements to the everlinQ Endovascular Access System; results were posted January 2, 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• everlinQ Endovascular Access System

Snippet

Sponsor: C. R. Bard | Conditions: Chronic Kidney Diseases | NA | Status: COMPLETED | Results posted: 2020-01-02